Covid-19 roundup: Mer­ck shares mol­nupi­ravir with a UN-backed non­prof­it; GSK halts Covid-19 re­search on mon­o­clon­al an­ti­body

Mer­ck has agreed to li­cense mol­nupi­ravir to UN-backed non­prof­it Med­i­cines Patent Pool.

The non­prof­it will be work­ing with mul­ti­ple drug­mak­ers to pro­duce mol­nupi­ravir for 105 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER